ALX Oncology Holdings Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.16 |
0.62 |
4.60 |
5.35 |
54.50 |
179.90 |
| Przychód Δ r/r |
0.00% |
-46.30% |
636.00% |
16.30% |
918.69% |
230.09% |
| Przychód (min) |
1.16 |
0.62 |
4.60 |
5.35 |
54.50 |
179.90 |
| Przychód (max) |
1.16 |
0.62 |
4.60 |
5.35 |
54.50 |
179.90 |
| EBITDA (średnia) |
0.70 |
0.38 |
2.76 |
3.21 |
32.70 |
107.94 |
| EBIT (średnia) |
0.70 |
0.38 |
2.76 |
3.21 |
32.70 |
107.94 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-145.62 |
-83.64 |
-62.20 |
-45.30 |
-52.96 |
-58.70 |
| Zysk netto % |
-12510.96% |
-13382.74% |
-1352.12% |
-846.72% |
-97.17% |
-32.63% |
| EPS (średnia) |
-2.76 |
-1.60 |
-1.19 |
-0.85 |
-1.01 |
-1.12 |
| Liczba analityków (Przychody) |
4 |
4 |
4 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
3 |
3 |
4 |
3 |
2 |
| symbol |
ALXO |
ALXO |
ALXO |
ALXO |
ALXO |
ALXO |